IDEA Collider: Innovation & Asymmetric Learning in Pharma

Dr. Christian Rommel on Oncology Innovations and Modern Drug Development at Bayer
In this episode of Idea Collider, host Mike Rea interviews Dr. Christian Rommel from Bayer. Dr. Rommel discusses his journey in molecular oncology from the Max Planck Institute, through roles at Roche, to overseeing global R&D at Bayer. He shares insights on turning scientific discovery into novel medicines, collaboration between scientists and commercial teams, and the importance of maintaining scientific integrity. Dr. Rommel also delves into the impact of AI in drug development, the potential of genetic medicines, and the complexities of launching new medicines on a global scale. The conversation also touches on embracing failure, internal and external partnerships, and the evolving landscape of clinical translation. 00:00 Introduction and Guest Welcome 00:25 Christian Rommel's Journey in Oncology 03:02 The Importance of Collaboration in Innovation 05:16 Balancing Risk and Reward in Drug Development 18:07 The Role of AI and Data in Modern R&D 22:33 Partnerships and External Learning 26:16 Balancing Legacy and Innovation in Biotech 27:18 Global Expansion and Leadership Diversity 27:27 Courage in Biotech Management 27:54 Inspiration from Roche Genentech 30:26 Commitment to Product Supply and Market Readiness 32:23 Challenges of Global Launches 35:53 Emerging Trends in Pharma: AI and Genetic Medicines 42:20 Decision-Making in Pharma 47:30 Reflections on Academic and Professional Journey Don't forget to Like, Share, Subscribe, Rate, and Review! Keep up with Christian Rommel; LinkedIn: https://www.linkedin.com/in/christian-rommel/ Website: https://www.bayer.com/en/innovation/science-research-and-innovation Follow Mike Rea On; Website: https://www.ideapharma.com/ X: https://x.com/ideapharma LinkedIn: https://www.linkedin.com/in/bigidea/ Listen to more fantastic podcast episodes: https://ideacollider.simplecast.com/
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
